Nomura/Instinet Starts Solid Biosciences (SLDB) at Buy

February 20, 2018 2:08 AM EST Send to a Friend
Nomura/Instinet initiates coverage on Solid Biosciences (NASDAQ: SLDB) with a Buy rating and a price target of $52.00.Analyst Chris ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login